BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang LM, Wang HJ, Li SL, Gan GH, Deng WW, Chang YS, Zhang LF. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors. World J Gastroenterol 2024; 30(11): 1533-1544 [PMID: 38617449 DOI: 10.3748/wjg.v30.i11.1533]
URL: https://www.wjgnet.com/2307-8960/full/v30/i11/1533.htm
Number Citing Articles
1
Shanshan Chen, Jian Ping Liu, Xinyu Li, Shoutao Dang, Wei Li. Sorafenib with or without co-interventions for hepatocellular carcinomaCochrane Database of Systematic Reviews 2025; 2025(6) doi: 10.1002/14651858.CD015851
2
Yun Tao, Jie Tang, Wenhui Yu, Wenge Yang, Jianwei Zhang, Qinghua Wu, Jie Li, Minghua Ren. The Role of MAPK12 in Prognosis of Patients With Liver Cancer and Effects on Stemness CharacteristicsStem Cells International 2025; 2025(1) doi: 10.1155/sci/9071464